Understanding Regulatory Frameworks And Documentation For Cannabis Products

Tips
Understanding Regulatory Frameworks And Documentation For Cannabis Products

If you buy ingredients for a cannabis product, the paperwork is part of the product. The rules behind it change by state line and, right now, by the month. This guide is written for brand owners, formulators and procurement teams. It reflects federal sources as of November 5, 2026. It is not legal advice.

There is no single rulebook

Cannabis is regulated at two levels that do not line up. Federal law, through the Controlled Substances Act, still treats marijuana as a Schedule I drug in general. States license and test cannabis on their own terms. A product can be legal under a state program and still sit in conflict with federal law, so compliance is built locally.

For a buyer the takeaway is simple: a supplier's "compliant" claim means little unless the documents match the jurisdiction you sell into.

Federal status in November 2026

Three things are moving at once. Keep them separate.

1. Marijuana: a partial move to Schedule III

Marijuana is still listed in Schedule I in 21 CFR 1308.11(d). On April 28, 2026, the Department of Justice published a final rule (91 FR 22714, effective that day) that moved part of it. 21 CFR 1308.13 now lists marijuana in Schedule III "in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license".

The broader proposal to move marijuana to Schedule III dates to a May 21, 2024 proposed rule. On April 28, 2026 the DEA withdrew its earlier hearing notice and announced a new hearing beginning June 29, 2026, citing Executive Order 14370. We did not find a final rule from that process in the Federal Register as of this writing. Read together, those two sections mean cannabis outside an FDA-approved product or a state medical license is still Schedule I.

2. Hemp: the definition is changing

The 2018 Farm Bill defined hemp as cannabis with no more than 0.3 percent delta-9 THC on a dry weight basis, and the FDA's cannabis guidance says such plants and derivatives are no longer controlled substances. The same law kept FDA authority over hemp-derived products in food, supplements and cosmetics.

Congress then rewrote the definition. Section 781 of Public Law 119-37, enacted November 12, 2025, takes effect 365 days later, in November 2026. Among other changes, it:

  • counts total THC, including THCA, against the 0.3 percent limit
  • excludes final hemp-derived cannabinoid products with more than 0.4 milligrams of total THC per container
  • excludes products containing cannabinoids that cannot be naturally produced by the plant, or that were synthesized or manufactured outside it

Then Congress delayed part of it. Section 2019 of H.R. 6500, signed September 2, 2026 as Public Law 119-103, says that until December 11, 2026 the section 781 amendments apply only to products with cannabinoids that cannot be naturally produced by the plant. The rest take effect after that date unless Congress acts again. If you sell or buy hemp-derived cannabinoid products, check this on the day you read it.

3. State programs run in parallel

States license cultivators, manufacturers, retailers and testing labs, and write their own testing panels. For most buyers the state regulator is the agency that matters day to day.

Documents a buyer should ask for

Certificate of Analysis (COA). A lab report for the batch you are buying. For cannabis products, state rules set what must be tested. California is one example: the Department of Cannabis Control says testing labs test for cannabinoids and terpenes, residual solvents and processing chemicals, residual pesticides, heavy metals, microbial impurities, mycotoxins, moisture content and water activity, and foreign material, and that California cannabis labs must maintain ISO/IEC 17025 accreditation. Other states use their own panels and action levels. Our guide to reading a terpene COA covers the terpene section in detail.

Safety Data Sheet (SDS). OSHA's Hazard Communication Standard, 29 CFR 1910.1200, sets a 16-section format, from identification and hazards through handling, storage, and other information. A COA tells you what is in a batch. An SDS tells you how to handle the material.

A statement of food-use status, if you need one. See the next section.

Other documents buyers commonly request. Stability data, a certificate of origin, and a copy of the supplier's license are common vendor-file items. They are practice, not a federal requirement, so ask for what your own compliance team needs.

A COA from one state is evidence of testing, not proof of compliance in another. If you sell in several states, expect to need lab results that satisfy each one.

Where terpene suppliers fit

Botanical terpenes such as limonene, myrcene, pinene, linalool and caryophyllene are common flavor and fragrance compounds. The federal schedules in 21 CFR 1308.11 through 1308.15 do not list any of them. That is a reading of the schedules, not a legal opinion. How a terpene taken from the cannabis plant is treated is a question for your state regulator and counsel. Our guide to cannabis-derived terpenes covers the sourcing side.

Many of these compounds also have food-use status. The FDA lists limonene and linalool among the flavoring substances regarded as generally recognized as safe for their intended use in food. The industry's FEMA expert panel reaffirmed the group of aliphatic and aromatic terpene hydrocarbons as GRAS in 2011, based on their use as flavoring in food.

That status is about food. It does not by itself address inhalation. If you make vape products, ask a supplier what it can show for that route, in addition to any GRAS statement. Our wholesale sourcing guide lists the other questions to ask before an order.

The Entour™ team is a division of The Werc Shop®, the first commercial cannabis laboratory to test for terpenes, in 2011, so we write documentation for a living. For the chemistry side of terpenes versus cannabinoids, see our guide on terpenes vs cannabinoids.

A short buyer checklist

  • Does the supplier provide a COA for each batch, not a generic product sheet?
  • Is the testing lab accredited to ISO/IEC 17025, and independent of the supplier?
  • Does the COA cover the panel your state requires?
  • Is there a current SDS for the material that actually ships?
  • Can the supplier state the food-use status of each ingredient, and say what it can show for inhalation?
  • Does the supplier's paperwork match the state you are selling in, and is it written into a terpene specification?
  • If you buy hemp-derived cannabinoid ingredients, have you checked them against the definition above?

This is a floor, not a ceiling. Larger accounts will ask for more.

FAQ

What is a COA in cannabis?

A Certificate of Analysis is a lab report on a specific batch. In states with mandatory testing it shows cannabinoid and terpene content and results for contaminant tests such as pesticides, heavy metals and microbials.

Is cannabis legal at the federal level in the US?

Generally no. Marijuana remains in Schedule I, with an April 2026 rule placing FDA-approved marijuana products and marijuana subject to a state medical license in Schedule III. Hemp, defined by statute, is treated differently, and that definition is changing in late 2026.

Are terpenes controlled substances?

The federal drug schedules do not list common terpenes such as limonene, myrcene, pinene, linalool or caryophyllene. How a terpene taken from the cannabis plant is treated is a question for your regulator and counsel.

What is the difference between a COA and an SDS?

A COA reports test results for a batch. An SDS covers hazards, handling, storage and related information for the material, in the 16-section format set out by OSHA.

Where to take this next

If you are comparing suppliers, talk to the team about documentation for your state before you place an order.

This article is general information, not legal advice. Rules change. Check with your state regulator and your own counsel before you rely on it.


About the author: The Entour™ team is a division of The Werc Shop®, the first commercial cannabis laboratory to test for terpenes back in 2011. The team formulates True To Plant® terpene profiles for licensed cannabis brands across the US, Canada, and tribal markets.

Read More